U.S. markets open in 5 hours 28 minutes
  • S&P Futures

    3,852.00
    +42.75 (+1.12%)
     
  • Dow Futures

    31,230.00
    +318.00 (+1.03%)
     
  • Nasdaq Futures

    13,108.50
    +197.50 (+1.53%)
     
  • Russell 2000 Futures

    2,249.70
    +50.50 (+2.30%)
     
  • Crude Oil

    62.54
    +1.04 (+1.69%)
     
  • Gold

    1,748.80
    +20.00 (+1.16%)
     
  • Silver

    26.97
    +0.52 (+1.99%)
     
  • EUR/USD

    1.2058
    -0.0029 (-0.24%)
     
  • 10-Yr Bond

    1.4600
    0.0000 (0.00%)
     
  • Vix

    25.01
    -3.88 (-13.43%)
     
  • GBP/USD

    1.3951
    +0.0029 (+0.21%)
     
  • USD/JPY

    106.7020
    +0.2000 (+0.19%)
     
  • BTC-USD

    47,145.85
    +2,581.96 (+5.79%)
     
  • CMC Crypto 200

    943.18
    +10.04 (+1.08%)
     
  • FTSE 100

    6,606.03
    +122.60 (+1.89%)
     
  • Nikkei 225

    29,663.50
    +697.49 (+2.41%)
     

ROCE Insights For Biolase

  • Oops!
    Something went wrong.
    Please try again later.
Benzinga Insights
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

Biolase (NASDAQ: BIOL) reported Q3 sales of $6.54 million. Earnings fell to a loss of $3.67 million, resulting in a 7.84% decrease from last quarter. In Q2, Biolase brought in $2.94 million in sales but lost $3.98 million in earnings.

What Is ROCE?

Return on Capital Employed is a measure of yearly pre-tax profit relative to capital employed by a business. Changes in earnings and sales indicate shifts in a company's ROCE. A higher ROCE is generally representative of successful growth of a company and is a sign of higher earnings per share in the future. A low or negative ROCE suggests the opposite. In Q3, Biolase posted an ROCE of -0.26%.

Keep in mind, while ROCE is a good measure of a company's recent performance, it is not a highly reliable predictor of a company's earnings or sales in the near future.

View more earnings on BIOL

Return on Capital Employed is an important measurement of efficiency and a useful tool when comparing companies that operate in the same industry. A relatively high ROCE indicates a company may be generating profits that can be reinvested into more capital, leading to higher returns and growing EPS for shareholders.

For Biolase, the return on capital employed ratio shows the current amount of assets may not actually be helping the company achieve higher returns, a note many investors will take into account when making long-term financial decisions.

Q3 Earnings Insight

Biolase reported Q3 earnings per share at $-0.21/share, which did not meet analyst predictions of $-0.05/share.

See more from Benzinga

© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.